Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: CompletedReview Status: Completed
